BIOCON — Biocon Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Biocon, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7,716	6,430	12,978	14,294	3,688
Depreciation
Non-Cash Items	6,423	8,260	10,148	4,814	10,433
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,177	-7,296	-9,275	4,634	-13,748
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities	12,104	18,525	29,539	40,612	19,940
Capital Expenditures	-19,248	-17,263	-19,316	-23,433	-19,117
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2,257	-125,555	9,271	21,092	-1,704
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-16,991	-142,818	-10,045	-2,341	-20,821
Financing Cash Flow Items	-1,096	-4,856	-8,474	-23,223	-67,692
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,421	130,487	-23,327	-18,540	-9,236
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,433	6,411	-3,804	20,043	-8,123